


Ask a doctor about a prescription for BIOCORYL 100 MG/ML INJECTABLE SOLUTION
Leaflet:information for the patient
Biocoryl 100 mg/ml injectable solution
procainamide hydrochloride
Read the entire leaflet carefully before starting to use this medicine,as it contains important information for you.
Contents of the leaflet
This medicine contains the active ingredient procainamide, which belongs to a group of medicines called class IA antiarrhythmics.
Biocoryl is used for the treatment of a type of heart rhythm disorder, ventricular arrhythmias, in adults.
Do not use Biocoryl:
Warnings and precautions
Consult your doctor before starting to use Biocoryl:
Children and adolescents
Biocoryl is not recommended for use in children and adolescents.
Using Biocoryl with other medicines
Tell your doctor if you are taking, have recently taken, or might take any other medicines.
Especially, tell your doctor if you are taking:
Using Biocoryl with food, drinks, and alcohol
Do not drink alcohol while being treated with this medicine, as it may reduce the effectiveness of the treatment.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.
Procainamide is not recommended during pregnancy or breastfeeding.
Driving and using machines
The effect of Biocoryl on the ability to drive and use machines is not known.
Biocoryl contains benzyl alcohol, sodium bisulfite, and sodium
This medicine contains 100 mg of benzyl alcohol in each vial (10 ml). Benzyl alcohol may cause allergic reactions.
This medicine may cause severe allergic reactions and bronchospasm (sudden feeling of suffocation) because it contains sodium bisulfite.
This medicine contains less than 1 mmol of sodium (23 mg) per 10 ml of this medicine; i.e., it is essentially "sodium-free".
Follow the administration instructions for this medicine exactly as indicated by your doctor. If in doubt, consult your doctor again.
Your doctor will decide what dose of Biocoryl you should receive and how often you need it.
Biocoryl should only be administered intramuscularly or intravenously. The intravenous route should be reserved for emergency cases.
The recommended dose by intramuscular route is 0.5 g of procainamide (5 ml of Biocoryl) followed by 0.5 to 1.0 g at intervals of 1-6 hours according to response.
The dose by intravenous route ranges from 0.2 g to 1.0 g of procainamide. The injection should be administered very slowly (no more than 1 ml of Biocoryl per minute) while monitoring blood pressure and having a vasoconstrictor (such as adrenaline) on hand in case of hypotension. An interval of 4-6 hours should elapse before administering, if necessary, a new dose.
Use in children and adolescents
Biocoryl is not recommended for use in children and adolescents.
If you use more Biocoryl than you should
If you take more Biocoryl than you should, consult your doctor immediately.
In case of overdose or accidental ingestion, consult your doctor, pharmacist, or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount taken.
It is recommended to take the package and leaflet of the medicine to the healthcare professional.
Information for the doctor:
Treatment of overdose or toxic manifestations includes general supportive measures, close monitoring, control of vital signs, and possibly administration of intravenous pressor agents and mechanical cardiorespiratory support.
Generally, if necessary, it can be treated by administering vasopressor agents after adequate volume replacement. It has been described that intravenous infusion of 1/6 M sodium lactate reduces the cardiotoxic effects of procainamide. It can be removed from circulation by hemodialysis, but not by peritoneal dialysis. There is no specific antidote known for procainamide overdose.
If you forget to use Biocoryl
Do not administer a double dose to make up for forgotten doses.
If you stop using Biocoryl
Your doctor will indicate the duration of your treatment with this medicine. Do not stop treatment before.
If you have any further questions about the use of this medicine, ask your doctor, pharmacist, or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The side effects observed are described below according to their frequency of occurrence:
Lupus-like syndrome (symptoms similar to those of a disease that can affect the skin, joints, kidneys, brain, and other organs).
Hypotension.
Neutropenia, thrombocytopenia, hemolytic anemia, agranulocytosis, second-degree atrioventricular block.
Decreased appetite, depression, psychotic disorder (delusions and hallucinations), hallucination, dizziness, balance disorder, dysgeusia (change in taste), flushing, nausea, vomiting, abdominal pain, diarrhea, hepatomegaly (inflammation of the liver), angioedema (skin inflammation), urticaria, pruritus (itching), maculopapular rash (skin rash), asthenia (weakness or fatigue), elevated transaminases (increase in certain liver enzymes).
Reporting side effects
If you experience any side effects, consult your doctor, pharmacist, or nurse, even if they are side effects not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date stated on the package after EXP. The expiration date is the last day of the month indicated.
This medicine does not require special storage conditions.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of the package and any unused medicine. This will help protect the environment.
Composition of Biocoryl
Appearance of the product and package contents
Biocoryl is a colorless or slightly yellowish, transparent injectable solution.
Biocoryl is available in packs of 1 vial.
Marketing authorization holder and manufacturer
Marketing authorization holder
Mana Pharma, S.L.
Carretera de Fuencarral, 22
Alcobendas, 28108 Madrid
Spain
Manufacturer
Ronda de Los Olivares, parcela 11
23009 Jaén
Spain
Date of the last revision of this leaflet:April 2022.
Other sources of information
Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/).
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for BIOCORYL 100 MG/ML INJECTABLE SOLUTION – subject to medical assessment and local rules.